Alström syndrome (AS) is a rare autosomal recessive ciliopathy caused by mutations in the ALMS1 gene. Hallmark characteristics include childhood onset of severe retinal degeneration, sensorineural hearing loss, obesity, insulin-resistant diabetes, and cardiomyopathy. Here we comprehensively characterize the auditory and otologic manifestations in a prospective case series of 38 individuals, aged 1.7-37.9 years, with genetically confirmed AS. Hearing loss was preceded by retinal dystrophy in all cases, and had an average age of detection of 7.45 years (range 1.5-15). Audiometric assessments showed mean pure tone averages (0.5, 1, 2, 4 kHz) of 48.6 and 47.5 dB HL in the right and left ears, respectively. Hearing was within normal limits for only 8/74 ears (11%). For the 66 ears with hearing loss, the degree was mild (12%), moderate (54%), or severe (8%). Type of hearing loss was predominantly sensorineural (77%), while three ears had mixed loss, no ears had conductive loss, and type of hearing loss was indeterminate for the remaining 12 ears. Serial audiograms available for 33 patients showed hearing loss progression of approximately 10-15 dB/decade. Our data show that hearing loss associated with AS begins in childhood and is a predominantly symmetric, sensory hearing loss that may progress to a severe degree. 2210 |
| INTRODUCTION
Alström syndrome (AS) (OMIM #203800) is a rare autosomal recessive ciliopathy first described in 1959 (Alström, Hallgren, Nilsson, & Åsander, 1959) . It is caused by mutations in the ALMS1 gene (2p13) that encodes the ciliary protein ALMS1 (Collin et al., 1999; Marshall et al., 2005) . Prevalence of AS is estimated at 1-9 per 1,000,000 persons (Marshall et al., 2005) , with approximately 700 cases described to date. AS is characterized by progressive sensorineural hearing loss (SNHL), severe retinal degeneration, childhood-onset obesity, insulin-resistant diabetes, hypertriglyceridemia, cardiomyopathy, hepatorenal and pulmonary disease, and normal intelligence (Marshall et al., 2005) , though with developmental delay given auditory and visual deficits. Diagnosis of AS is made based on clinical diagnostic criteria and confirmed by mutations in ALMS1 (Marshall et al., 2005; Ozantürk et al., 2015) . Typically, patients present within the first years of life with retinal degeneration that progresses to blindness in the second decade. Nystagmus and photophobia are common. Impaired vision is most often followed or accompanied by a post-lingual SNHL, though cases with hearing loss at birth have been reported (Ozantürk et al., 2015) . Life expectance rarely exceeds 50 years of age (Marshall, Maffei, Collin, & Naggert, 2011) , due to complications of cardiomyopathy, diabetes, hypertriglyceridemia, and progressive multi-organ dysfunction associated with systemic fibrosis (Álvarez-Satta, Castro-Sánchez, & Valverde, 2015) . From an otologic standpoint, chronic recurrent otitis media (ROM) as late as the third decade of life is commonly reported, with a higher than estimated prevalence of approximately 42-54% (Marshall et al., 2005; Marshall, Paisey, Carey, & Macdermott, 2003) .
While progressive decline in pure tone sensitivity has been documented in patients with AS (Bahmad et al., 2014; Welsh, 2007) , the auditory profile has not been fully characterized. Distortion product otoacoustic emissions (DPOAEs) and auditory brainstem responses (ABRs), which are critical assessments for discerning sensory versus neural hearing loss, have been reported for two siblings (Bahmad et al., 2014) , but have not been reported for a cohort study.
Here we present comprehensive audiologic data and otologic findings on 38 individuals with AS, all prospectively evaluated at a tertiary clinical research center. In addition, we report the progression rate of hearing loss in AS calculated based on our analysis of historical audiograms of patients. 
| Audiologic evaluations
Age-and ability-appropriate audiologic evaluations including air-and bone-conduction pure-tone thresholds, speech thresholds, and evaluation of word recognition ability in quiet were conducted at the NIH Clinical Center using a Grason Stadler (Eden Prairie, MN) diagnostic audiometer (GSI-61) in sound suites meeting American National Standards Institute (ANSI 2010) criteria. Middle ear function was assessed using 226 Hz tympanometry. DPOAEs were evaluated in quarter octave bands over the frequency range 842-7996 Hz using an Otodynamics (Hatfield, Hertfordshire, UK) Echoport Otoacoustic Emission System supported by ILO V6 Clinical OAE software. DPOAEs were interpreted as present over a broad frequency range when the signal to noise ratio exceeded 6 dB for seven or more of the 14 tested frequency bands, and present at a limited number of frequencies when emissions were present at six or fewer bands. ABRs were recorded in response to separately presented condensation and rarefaction, airconducted, broadband clicks delivered via insert earphones at 85/95 dB nHL at click repetition rates of 8.3 and 63.3/sec (GSI Audera, Eden Prairie, MN) using an Fz to ipsilateral and contralateral earlobe surface electrode montage.
In addition, we obtained past audiometric records for review and included 125 historical audiograms from 33 patients in our analysis to examine longitudinal age-related trends and determine rate of progression of hearing loss in AS. Only behavioral data obtained with good reliability as judged by the assessing audiologist were included.
| Otologic evaluation
Detailed medical histories and comprehensive otologic examinations performed by a single otologist (HJK) included a head and neck examination as well as microscopic examination of both ears.
| Data interpretation and analysis
Audiometric data gathered at the NIH visit were designated as the reference audiogram and used for all cross sectional analyses.
Degree of hearing loss was based on air conduction pure tone thresholds. Classifications were as follows: within normal limits (WNL) when ≤20 dB HL, mildly reduced when >20-40 dB HL, moderately reduced when >40-70 dB HL, severely reduced when >70-95 dB HL, and profoundly reduced when >95 dB HL (Mazzoli et al., 2003) . Overall degree of hearing loss was based on a four frequency pure-tone average (4F-PTA; 0.5/1/2/4 kHz). Type of hearing loss was based on the difference between the air-and boneconduction thresholds for a three frequency pure-tone average (3F-PTA; 0.5/1/2 kHz). Hearing loss was classified as sensorineural when the air-conduction 3F-PTA >20 dB HL and 3F-PTA air-bone difference <10 dB; conductive when the air-conduction 3F-PTA LINDSEY ET AL. | 2211 >20 dB HL, the bone conduction 3F-PTA ≤ 20 dB HL and the 3F-PTA air-bone difference ≥10 dB; and mixed when both the air-and boneconduction 3F-PTA >20 dB HL and the 3F-PTA air-bone difference were ≥10 dB (Mazzoli et al., 2003 (Mazzoli et al., 2003) .
Word recognition scores were evaluated as proportionate or disproportionate to the degree of hearing loss, based on the 3F-PTA using ranges established by Dubno, Lee, Klein, Matthews, & La, 1995 . Peak static compliance and middle ear pressure were interpreted as WNL/low/high and WNL/negative/positive, respectively, using age appropriate norms (Margolis & Heller, 1987) . ABR latencies were interpreted as WNL/late based on normative data from Schwartz, Pratt, & Schwartz, 1989. 
| Data analysis
Data were analyzed using Microsoft Excel (version 14.5.1) and GraphPad Prism 6.0h (La Jolla, CA). Descriptive statistics were computed for hearing loss type and degree, tympanometry, and patterns of hearing loss progression. Simple linear regressions were used to examine hearing thresholds by air conduction as a function of age. Fisher's exact test was used to determine if there was an association between history of ROM and AS. Paired Student's t-tests were conducted to compare hearing sensitivity between the right and left ears for the 4F-PTA. One-way analysis of variance (ANOVA) was used to investigate differences between the 4F-PTA for decade-based age groups. Post-hoc analyses investigating group differences were conducted using Tukey's multiple comparisons test. Statistical significance was set at p ≤ 0.05.
| RESULTS

| Patient characteristics and clinical findings
The patient cohort included 20 females and 18 males; ages at the time of NIH examination ranged from 1.7 to 37.9 years (M 16.0, SD 10.5).
One family contributed three siblings, and four families contributed two siblings each, including two sets of dizygotic twins, leaving 32 independent families. There were 12 patients aged 1-10, 14 patients aged 11-20, five patients aged 21-30, and six patients aged 31-40 years old. Races included 35 Caucasians and three African-Americans.
Bi-allelic pathological variants of the ALMS1 gene were identified in 31 of the 32 families; in one family the second pathological variant could not be identified (Supplemental Table S1 ). All pathological variants were null, resulting in frame shifting or stop codons. Eight families were homozygous while 23 were compound heterozygous (Supplemental Table S1 ).
The average age of HL detection occurred at 7.45 years (range 1.5-15). For 15 patients who had neonatal hearing screening information available, all but one patient passed. A history of sinusitis and nasal congestion were reported in 19/38 (50%) and 18/38 (47.4%) patients, respectively (Table 1) . Of note, a history of frequent otitis media was reported by 35 of 38 patients (92%); 19/38 (50%) had a history of pressure equalization tube placement.
On microscopic ear examination (HJK), four patients had serous middle ear effusions, five patients had patent pressure equalization tubes (9 ears), and seven patients showed evidence of myringosclerosis. All patients had nystagmus and evidence of retinal dystrophy.
Cranial nerve evaluation was otherwise within normal limits.
In all patients, vision loss preceded hearing loss. While none of the patients had a history of vertigo, nine reported intermittent dysequilibrium. Other relevant clinical findings identified during clinical examination are presented in Table 1 .
| Cross sectional analysis of auditory function
Hearing thresholds were obtained on 37/38 patients (74/76 ears) at the NIH visit. One patient, from one of the twin sibships, did not cooperate with the audiologic evaluations due to significant developmental delay caused by perinatal asphyxia. Hearing was symmetrical in 28/29 patients with sufficient pure tone thresholds to make this determination. One patient, aged 10 years, had a 15 dB difference between ears at two frequencies (3 and 8 kHz), although her hearing was classified as normal in both ears based on the 4F-PTA. Pure tone configurations were flat in 36 ears, gently sloping in 23 ears, and low frequency ascending in one ear. There was not sufficient pure tone data to calculate configuration for the remaining ears (n = 14).
Hearing thresholds were normal in 10.8% (8/74) of ears ( Table 2) .
Degree of hearing loss was mild in 12.2% (9/74) of ears, moderate in 54.1% (40/74) of ears, and severe in 8.1% (6/74) of ears. Degree of hearing loss could not be determined in 14.9% of ears, all of which Data are presented as number of persons with finding/number assessed.
were in the youngest age group (1-10 years), due to insufficient hearing threshold data. Normal hearing and mild hearing loss were observed in the youngest two age groups (1-10 and 11-20 years), but not in the older groups (21-30 and 31-40 years). Of the 66 ears with hearing loss, the type was sensorineural for 77.3% (51/66), mixed for 4.5% (3/66) (Table 3) , and no ears had pure conductive hearing loss.
Sensorineural hearing loss was observed in all age groups, and was the only type measured in the older two age groups. Type of hearing loss was unknown for 18.2% (12/66) of ears, all of which were in the youngest group (1-10 years) of patients.
Analysis of this cross sectional data shows, on average, a 10 dB decline in pure tone thresholds between decade-based age groups (Table 4 ). There was negative middle ear pressure with normal mobility in 12.2% (9/74). Flat tympanograms were observed in 13.5% (10/74); in nine cases this finding was associated with patent pressure equalization tubes.
DPOAEs were absent in 71.2% (46/64) of ears (Table 4 ), all of which had hearing loss of mild or greater degree. DPOAEs were present across a broad frequency range in 12 ears, which included normal hearing (n = 8), a mild hearing loss (n = 2), or no threshold data (n = 2). In the three ears with DPOAEs present over a limited frequency range, two had a mild hearing loss and one had mildly negative middle ear pressure with no behavioral threshold data.
ABRs were evaluated in 30 patients (60 ears) ( Table 4) ANOVA showed a statistically significant difference in hearing levels between all age groups from the first through fifth decade of life. This supports the notion of worsening hearing level with increasing age.
Hearing loss configuration was either flat or had a gently sloping pattern across the audiometric test frequency range for the majority of patients. For those 15 patients for whom newborn screening data were available, all but one passed the newborn hearing screening, consistent with a predominantly postnatal onset of the hearing loss. Since almost all patients with AS develop SNHL in childhood, it is important that they have close monitoring of their hearing status and receive prompt and proper aural amplification and accommodations. This is especially important for these patients with compromised vision for whom auditory cues are integral to safety, education, and communication.
Our patients demonstrated a history of frequent middle ear infections at a rate greater than that noted to occur in the general population (92% vs. 30%) (Hoffman et al., 2013) . Additionally, our patient group had a PET placement rate of 50% in contrast to one study which determined the average incidence of PET placement in developed countries to be 30% or less by age five (Djurhuus, Skytthe, Christensen, & Faber, 2014) . Despite these facts, the majority of our patients did not show a conductive component to their hearing loss, either in our cross sectional data (Table 3) During differentiation in mouse lung development and repair after injury, primary cilia are transiently present and give way to motile cilia, suggesting that primary cilia may play a role in control programming of differentiation of motile ciliogenesis early in life (Jain et al., 2010) . It is plausible that the ciliopathy from ALMS1 mutation may delay or alter normal development of motile cilia of the respiratory epithelial cells found in the middle ears and paranasal sinuses. Perhaps this primary ciliary effect on the normal respiratory epithelium maturation may predispose patients with AS to recurrent upper and lower respiratory infection early in life, which they eventually outgrow as the respiratory epithelial lining develops fully.
The ALMS1 protein is ubiquitously expressed in fetal and postnatal tissues; at the subcellular level it localizes to the centrosome, basal bodies of the cilia, cytoplasm, cytoskeleton, and microtubule organizing center (Collin et al., 2002; Hearn et al., 2002) . Although its function is not completely understood, current evidence suggests that ALMS1 plays roles in formation and maintenance of cilia, cell cycle regulation, endosomal trafficking, cell migration, and extracellular matrix production (Collin et al., 2012; Favaretto et al., 2014; Knorz et al., 2010; Leitch, Lodh, Prieto-Echagüe, Badano, & Zaghloul, 2014; Shenje et al., 2014; Zulato et al., 2011) . In the developing organ of Corti, ALMS1 is concentrated in basal bodies at the base of the cilia and supporting cells, in the basal bodies of the marginal cells in stria The dotted line indicates the 95th percentile confidence limit for the maximum WRS as a function of the 3F-PTA; scores in the shaded area are considered disproportionately poor in relation to the degree of hearing loss (Dubno et al., 1995) vascularis, and in the mesenchymal fibroblasts located on the spiral ligament and underside of the basilar membrane (Jagger et al., 2011) .
Mice with defective ALMS1 show abnormalities of the shape and orientation of stereocilliary bundles and adult animals lose outer hair cells and develop progressive large vacuoles in the stria vascularis (Jagger et al., 2011; Nadol, Marshall, & Bronson, 2015) . Additionally, Jagger et al. (2011) observed an accelerated loss of cochlear outer hair cells in mature Alms −/− mice as compared to mature control mice, while Nadol et al. (2015) observed loss of both outer and inner hair cells in humans with AS. The combination of our findings on pure tone audiometry, absent DPOAEs, proportionate word recognition scores, and robust ABRs suggest an outer hair cell and/or stria vascularis site of lesion, consistent with findings in the Alms1-disrupted animal models (Jagger et al., 2011) . It should be noted however, that the endocochlear potentials within four test mice were within the normal range, despite the presence of vacuolar degeneration, which further confounds the role of the stria vascularis in the pathophysiology.
We identified robust ABRs in spite of significant sensorineural hearing loss indicating that hearing loss in AS is predominantly cochlear-based. Abnormal ABR findings that could not be explained by the degree of hearing loss were observed in only four patients (6 ears).
MRI of the brain and temporal bone available in one of these patients with an abnormal ABR demonstrated normal anatomy. Abnormal ABRs in these four patients raises the possibility of retrocochlear auditory dysfunction in a subset of patients with AS. These patients in our cohort may have central auditory nervous system involvement similar to the subset of patients with AS with structural brain abnormalities reported by Citton et al. (2013) . Most neurons and glial cells possess non-motile solitary primary cilia, which are involved in cell signaling receptors and processes (Narita & Takeda, 2015) .
The presence of a functioning cochlear nerve and retrocochlear pathway are important parameters with implications for the approach to management of hearing loss. The robust ABRs and proportionate word recognition scores indicate that AS patients should benefit from traditional aural amplification and if necessary, cochlear implantation.
Twenty-seven of the 38 patients in our cohort use hearing aids and there is at least one report of successful cochlear implantation in a patient with AS (Florentzson, Hallén, & Möller, 2010) .
Based on clinical examination and the relative lack of vertigo and imbalance, there is little evidence in our population to suggest significant vestibular involvement. Dedicated vestibular assessments
were not conducted and further research on the role of ALSM1 in the vestibular system is needed. However, given the presence of spontaneous nystagmus, a comprehensive vestibular assessment would be limited.
| Limitations of this study
It is important to note that there was variability among the number of historical audiograms available for each patient, with some patients lacking data altogether and others with multiple hearing tests. It is possible this may have an effect on our data analysis.
Additionally, the number of patients older than 30 years is limited (6 of 38), preventing further analysis of hearing levels with older age.
In our cohort conductive hearing loss was rare and patients did not have evidence of active ear infections at the time of NIH examination, perhaps due to the fact that ill patients were not allowed to travel to the NIH. 
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